pH-responsive chitosan-sodium alginate nanocarriers for curcumin delivery against brain cancer

被引：1

作者：

Shabestari, Salar Mohammadi ^{[1
]}

Pourmadadi, Mehrab ^{[2
,3
]}

Abdouss, Hamidreza ^{[1
]}

Ghanbari, Taranom ^{[4
]}

Abdouss, Majid ^{[5
]}

Rahdar, Abbas ^{[6
]}

Cambon, Adriana ^{[7
,8
]}

Taboada, Pablo ^{[7
,8
]}

机构：

[1] Univ Tehran, Coll Engn, Sch Chem Engn, Dept Polymer, Tehran, Iran

[2] Shahid Beheshti Univ, Prot Res Ctr, GC, Tehran 1983963113, Iran

[3] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn & Appl Cell Sci, Student Res Comm, Tehran, Iran

[4] Tarbiat Modares Univ, Fac Chem Engn, Polymer React Engn Dept, POB 14155-143, Tehran, Iran

[5] Amirkabir Univ Technol, Dept Chem, Tehran, Iran

[6] Univ Zabol, Dept Phys, Zabol, Iran

[7] Univ Santiago De Compostela, Mat Inst IMATUS, Particle Phys Dept, Colloids & Polymers Phys Grp, Santiago De Compostela 15782, Spain

[8] Univ Santiago De Compostela, Hlth Res Inst IDIS, Santiago De Compostela 15782, Spain

来源：

COLLOIDS AND SURFACES B-BIOINTERFACES | 2025年 / 255卷

关键词：

Chitosan/sodium alginate-based nanoparticles; Cerium oxide; Curcumin; Brain cancer; DRUG-DELIVERY; OXIDE; NANOPARTICLES; CELLULOSE; MATRIX;

D O I：

10.1016/j.colsurfb.2025.114875

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Curcumin (CUR) exhibits potent anticancer properties and has been widely investigated for the treatment of various malignancies. However, its clinical application is limited by poor aqueous solubility, rapid systemic metabolism, and a short circulation half-life. In the present study, a pH-responsive hybrid nanocarrier system was developed based on sodium alginate (SA), chitosan (CS), and cerium oxide (CeO2) nanoparticles (NPs), using a water-in-oil-in-water (W/O/W) double emulsion technique. This system was designed to enhance CUR stability, enable controlled and sustained release, and improve pharmacokinetic parameters such as half-life and biodistribution. The resulting nanocarriers exhibited spherical morphology with textured surfaces, a positive surface charge, and nanoscale dimensions. Structural characterization via XRD and FTIR confirmed a quasi-amorphous composite matrix and successful encapsulation of CUR, achieving an encapsulation efficiency of approximately 86 %. Drug release studies conducted at physiological and acidic pH demonstrated a sustained, pH-dependent release profile, well-fitted by the Baker-Lonsdale kinetic model. Cytotoxicity assays using U-87MG2 glioma and healthy astrocyte cell lines indicated that the CUR-loaded nanocarriers selectively induced tumor cell death while exhibiting minimal toxicity toward normal cells. Moreover, the inclusion of CeO2 NPs was found to mitigate CUR degradation under physiological conditions, thereby contributing to its enhanced therapeutic performance. Flow cytometry analysis further revealed a significant induction of apoptosis in glioma cells treated with the CUR-loaded nanocomposites. Collectively, these findings underscore the potential of the developed CS/ SA/CeO2@CUR nanoplatform as an effective and biocompatible strategy for brain cancer therapy.

引用

页数：15

共 84 条

[1]

Zhao Y., Yue P., Peng Y., Sun Y., Chen X., Zhao Z., Han B., Recent advances in drug delivery systems for targeting brain tumors, Drug Deliv., 30, pp. 1-18, (2023)

[2]

Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Cancer J. Clin., 71, pp. 209-249, (2021)

[3]

Reifenberger G., Wirsching H.-G., Knobbe-Thomsen C.B., Weller M., Advances in the molecular genetics of gliomas — implications for classification and therapy, Nat. Rev. Clin. Oncol., 14, pp. 434-452, (2017)

[4]

Nguyen T.T.T., Greene L.A., Mnatsakanyan H., Badr C.E., Revolutionizing brain tumor care: emerging technologies and strategies, Biomedicines, 12, (2024)

[5]

Salahshour P., Nanobiomaterials/bioinks based scaffolds in 3d bioprinting for tissue engineering and artificial human organs, Adv. Biol. Earth Sci., 9, pp. 97-104, (2024)

[6]

Nasibova A., The modern perspectives of nanomaterial applications in cancer treatment and drug delivery, Adv. Biol. Earth Sci., 9, pp. 330-337, (2024)

[7]

Qiu Z., Yu Z., Xu T., Wang L., Meng N., Jin H., Xu B., Novel nano-drug delivery system for brain tumor treatment, Cells, 11, (2022)

[8]

Shabestari S.M., Jafari S.H., Benisi S.Z., Khoeini R., Shojaei S., Ghorbani M., Goodarzi V., Role of phosphate-modified cellulose into the scaffold based on poly (glycerol azelaic acid)-co-poly(ε-caprolactone) for using bone regenerative Medicine, Int. J. Biol. Macromol., 304, (2025)

[9]

Unnisa A., Greig N.H., Kamal M.A., Nanotechnology: a promising targeted drug delivery system for brain tumours and Alzheimer's disease, Curr. Med. Chem.., 30, pp. 255-270, (2023)

[10]

Ezike T.C., Okpala U.S., Onoja U.L., Nwike C.P., Ezeako E.C., Okpara O.J., Okoroafor C.C., Eze S.C., Kalu O.L., Odoh E.C., Nwadike U.G., Ogbodo J.O., Umeh B.U., Ossai E.C., Nwanguma B.C., Advances in drug delivery systems, challenges and future directions, Heliyon, 9, (2023)

← 1 2 3 4 5 6 7 8 9 →